/Companies

Mimikai

Portland, US · Founded 2017 · Delaware corporation · 4 known investors

Find your way into Mimikai

Each arrow is one introduction. Sign up to fill in the first one.

8 people can intro you to Stephanie

Ask James Joaquin to introduce you to Stephanie Watson

You →James · together at Seventh Generation →Stephanie

Sign up to find every way you can get introduced to Mimikai

  • Your email: who you already know at Mimikai, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Mimikai team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Mimikai makes a plant-based insect repellent using undecanone, a natural compound derived from wild tomato plants, marketed as an EPA-registered spray for mosquito and tick protection. The product is positioned as a non-toxic, non-irritating consumer alternative to conventional and essential-oil repellents.

Founders & leadership

Mimikai was founded in 2017 by Michelle Arnau.

MAMichelle Arnau
Michelle ArnauChief Executive Officer
SWStephanie Watson
Stephanie WatsonFounder, PresidentStephanie Watson is President of Mimikai and has 16 years of experience launching and operating sustainable consumer product brands across multiple markets.
DG
Damon GorrieNamed on SEC filing

Board

MM
Martin MulvihillBoard director
FL
Frank LinBoard director
SSStephanie Sarelakos
Stephanie SarelakosBoard directorPrincipal at The Venture Collective

Investors · 4

Reported raises · per SEC filings

Form D private placements

$5.7M disclosed across 4 rounds · 2018–2024

▶$4MraisedNov 2024 · 25 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin MulvihillDirector
  • Stephanie WatsonExecutive Officer, Director
  • Michelle ArnauExecutive Officer, Director
  • Frank LinDirector
  • Stephanie SarelakosDirector
Offering amount
$4M
Amount sold
$4M
Proceeds to insiders
$860K
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$130.7KraisedMar 2023 · 9 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephanie WatsonExecutive Officer, Director
  • Martin MulvihillDirector
  • Damon GorrieDirector
  • Frank LinDirector
Offering amount
$600K
Amount sold
$130.7K
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$545.5KraisedAug 2021 · 11 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank LinDirector
  • Damon GorrieDirector
  • Martin MulvihillDirector
  • Stephanie WatsonExecutive Officer
Offering amount
$750K
Amount sold
$545.5K
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedJan 2018 · 20 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Damon GorrieExecutive Officer
  • Stephanie WatsonExecutive Officer, Director
Offering amount
$1.7M
Amount sold
$1M
First sale
Jan 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Mimikai.

Frequently asked questions

What does Mimikai do?
Mimikai makes a plant-based insect repellent using undecanone, a natural compound derived from wild tomato plants, marketed as an EPA-registered spray for mosquito and tick protection. The product is positioned as a non-toxic, non-irritating consumer alternative to conventional and essential-oil repellents.
Who founded Mimikai?
Mimikai was founded by Michelle Arnau in 2017.
Who are Mimikai's investors?
Mimikai's investors include Safer Made, The Venture Collective, Wolfpack Investor Network, Human Ventures.
How much funding has Mimikai raised?
Mimikai has disclosed $5.7M raised across 4 rounds.
Where is Mimikai headquartered?
Mimikai is headquartered in Portland, US.